82467-2
riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay
Active
Term Description
This serum rituximab drug level is intended for quantitative measurements of rituximab levels in human serum to aid in patient-specific therapeutic drug monitoring and dosing for individuals with non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL) and rheumatoid arthritis.
Part Description
LP220253-1 riTUXimab
Rituximab (trade names Rituxan, MabThera and Zytux) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is thus used to treat diseases that are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemia, transplant rejection and autoimmune disorders. Rituximab is also used with methotrexate to treat moderate-to-severe forms of rheumatoid arthritis to decrease joint pain and swelling. It is usually used for arthritis only after other medications have not worked. It is also used to treat certain types of blood vessel disease (such as Wegener's granulomatosis, microscopic polyangiitis).
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- riTUXimab:
MCnc: Pt: Ser/Plas: Qn: IA - Long Common Name
- riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay
- Short Name
- riTUXimab SerPl IA-mCnc
- Display Name
- riTUXimab IA [Mass/Vol]
- Consumer Name Alpha Get Info
- riTUXimab, Blood
Part Model Get Info
- Component
- riTUXimab
LP220253-1
- Analyte
- riTUXimab
LP220253-1
- Component Numerator
- riTUXimab
LP220253-1
- Component Numerator Core
- riTUXimab
LP220253-1
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- MCnc
LP6827-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Qn
LP7753-9
- Method
- IA
LP217197-5
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.58
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 12473
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Rituximab: |
| el-GR | Greek (Greece) | Ριτουξιμάμπη: Synonyms: DRUG/TOX IA MCnc Pt Qn Ορός Ορός/Πλάσμα Πλάσμα Ριτουξιμάμπη |
| es-ES | Spanish (Spain) | Rituximab: Synonyms: Cuantitativo |
| es-MX | Spanish (Mexico) | riTUXimab: |
| fr-FR | French (France) | Rituximab: |
| it-IT | Italian (Italy) | Rituximab: Synonyms: Concentrazione di Massa Immunoassay Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | rituximab: Synonyms: IA |
| zh-CN | Chinese (China) | 利妥昔单抗: Synonyms: 免疫测定; |
Example Units
| Unit | Source |
|---|---|
| ug/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://